June 2021
Volume 62, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2021
Progression of Diabetic Retinopathy in Presence of Age-related Macular Degeneration
Author Affiliations & Notes
  • Miin Roh
    Ophthalmology, Harvard Medical School, Joslin Diabetes Center, Boston, Massachusetts, United States
  • Michael Gilbert
    Northwest Vision Institute, Bellevue, Washington, United States
    Ophthalmology, Harvard Medical School, Joslin Diabetes Center, Boston, Massachusetts, United States
  • mohamed Ashraf Elmasry
    Ophthalmology, Alexandria University, Alexandria, Egypt
    Ophthalmology, Harvard Medical School, Joslin Diabetes Center, Boston, Massachusetts, United States
  • Jae Rhee
    Ophthalmology, Harvard Medical School, Joslin Diabetes Center, Boston, Massachusetts, United States
  • Abdulrahman Rageh
    Ophthalmology, Harvard Medical School, Joslin Diabetes Center, Boston, Massachusetts, United States
  • Paolo S Silva
    Ophthalmology, Harvard Medical School, Joslin Diabetes Center, Boston, Massachusetts, United States
  • Jennifer K Sun
    Ophthalmology, Harvard Medical School, Joslin Diabetes Center, Boston, Massachusetts, United States
  • Lloyd Paul Aiello
    Ophthalmology, Harvard Medical School, Joslin Diabetes Center, Boston, Massachusetts, United States
  • Footnotes
    Commercial Relationships   Miin Roh, None; Michael Gilbert, None; mohamed Elmasry, None; Jae Rhee, None; Abdulrahman Rageh, None; Paolo Silva, None; Jennifer Sun, None; Lloyd Aiello, None
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science June 2021, Vol.62, 1091. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Miin Roh, Michael Gilbert, mohamed Ashraf Elmasry, Jae Rhee, Abdulrahman Rageh, Paolo S Silva, Jennifer K Sun, Lloyd Paul Aiello; Progression of Diabetic Retinopathy in Presence of Age-related Macular Degeneration. Invest. Ophthalmol. Vis. Sci. 2021;62(8):1091.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To evaluate the association between the presence of age-related macular degeneration (AMD) and progression of diabetic retinopathy (DR).

Methods : We retrospectively identified patients with at least mild nonproliferative diabetic retinopathy (NPDR), with or without AMD at the Joslin Diabetes Center. Inclusion criteria were age >50yrs, baseline visit between 2007-2014, >3 years of follow-up, and ICD-9/10 diagnosis code of mild to severe nonproliferative diabetic retinopathy (NPDR) with or without AMD. Patients were excluded if they had received prior anti-vascular endothelial growth factor (VEGF) injections or had proliferative DR (PDR) or neovascular AMD at baseline. AMD grading used the Age-Related Eye Disease Study classification system. DR progression was defined as >2-step progression in clinical grade or progression to PDR. Multivariable Cox regression analysis and Cox proportional hazards regression model were used to assess factors associated with progression of DR. Mediation analysis was performed in patients who had both baseline hemoglobin A1c (HbA1c) and average HbA1c values to investigate whether average HbA1c mediates the association between the presence of AMD and progression of DR.

Results : After exclusion, there were 223 eyes (138 patients) with DR with AMD and 476 eyes (260 patients) with DR without AMD included in the analysis. A total of 61 eyes (9.87%) had either ≥2-step progression of DR or progression to PDR during the follow up period (50 eyes (7.5%) had ≥2-step progression of DR and 46 eyes (6.6%) progressed to PDR). The rates of ≥ 2-step DR progression (HR 0.34, 95% CI 0.12~0.97, p=0.044) and progression to PDR (HR 0.34, 95% CI 0.13~0.90, p=0.0304) were lower in eyes with AMD compared to eyes without AMD in multivariable Cox regression analysis. Mediation analysis revealed that the association between the presence of AMD and decreased progression of DR was not affected by diabetic control measured by average HbA1c. Subgroup analysis revealed that there is a possible protective effect against ≥2-step DR progression and/or progression to PDR with lower HbA1c at baseline and current smoking status.

Conclusions : There is a lower rate of DR progression in patients with mild to severe NPDR when AMD coexists at baseline compared to those without AMD. The presence of AMD may have a protective effect against DR progression independent of diabetic control measured by HbA1c.

This is a 2021 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×